Company Overview
General information about the GlaxoSmithKline company
GlaxoSmithKline (GSK) is a multinational pharmaceutical and healthcare company headquartered in Brentford, London. The company was formed in 2000 through the merger of British company Glaxo Wellcome and American company SmithKline Beecham. It is one of the largest pharmaceutical companies in the world and is focused on the research, development, and marketing of prescription medicines, vaccines, and consumer healthcare products.
History:
The history of GlaxoSmithKline can be traced back to the establishment of two independent companies: Joseph Nathan and Co. in New Zealand in 1873 and Burroughs Wellcome & Company in the UK in 1880. In 1995, Glaxo Wellcome PLC was formed through the merger of Glaxo and Burroughs Wellcome. SmithKline Beecham PLC was formed in 1989 through the merger of SmithKline Beckman Corporation and Beecham Group PLC. In 2000, the two companies merged to form GlaxoSmithKline.
Products:
GSK's product portfolio includes prescription medicines, vaccines, and consumer healthcare products. Its prescription medicines cover a broad range of therapeutic areas, including respiratory, HIV, oncology, and neurosciences. The company also offers vaccines for diseases such as influenza, meningitis, and shingles. Its consumer healthcare products include over-the-counter medicines, oral care, nutrition, and skin health products.
Research and Development:
GSK has a strong focus on research and development (R&D) and invests heavily in this area. The company has R&D facilities in the UK, US, Belgium, and China, among others. Its R&D efforts are focused on discovering and developing new medicines and vaccines for a wide range of diseases and conditions. GSK collaborates with academic institutions, governments, and other industry partners to advance its research efforts.
Corporate Responsibility:
GSK is committed to operating ethically and responsibly, with a focus on sustainability and corporate social responsibility. The company has various initiatives in place to reduce its environmental impact and improve access to healthcare for underserved populations. It also has policies in place to ensure ethical business practices and compliance with laws and regulations.
Financials:
In 2020, GSK reported revenues of Β£34 billion and a net income of Β£5.5 billion. The company employs over 100,000 people globally and has a presence in over 150 countries. Its primary stock exchange listings are on the London Stock Exchange and the New York Stock Exchange.
Partnerships:
GSK has formed partnerships with various organizations to further its research and development efforts, expand its product portfolio, and improve access to healthcare. Some notable collaborations include:
- Joint ventures with Pfizer in the areas of consumer healthcare and HIV treatment
- Collaboration with Sanofi to develop a COVID-19 vaccine
- Partnership with Innoviva to develop respiratory treatments
- Collaboration with Vir Biotechnology to develop pandemic treatments
- Partnership with the Bill & Melinda Gates Foundation to develop vaccines for malaria and tuberculosis
Summary:
GlaxoSmithKline is a multinational pharmaceutical and healthcare company focused on research, development, and marketing of prescription medicines, vaccines, and consumer healthcare products. It has a strong history and presence in the market, with a commitment to corporate responsibility and ethical business practices. The company has a diverse range of products and partnerships that contribute to its strong financial performance.
What is special about the GlaxoSmithKline company?
There are several key factors that make GlaxoSmithKline (GSK) a unique and special company:
1. Size and Scope: GSK is one of the largest pharmaceutical companies in the world, with operations in over 150 countries and a vast portfolio of products spanning prescription medicines, consumer healthcare, and vaccines.
2. History and Legacy: GSK has a rich history dating back to the 19th century, with the merger of GlaxoWellcome and SmithKline Beecham in 2000 solidifying its position as a major player in the healthcare industry.
3. Research and Development: Innovation and research are at the heart of GSK's business, with significant investments made in discovering and developing new medicines to meet unmet medical needs.
4. Commitment to Global Health: GSK's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. The company is dedicated to addressing global health challenges, such as infectious diseases and access to healthcare in developing countries.
5. Diverse Portfolio: GSK has a diverse portfolio of products, including market-leading brands such as Advair, Sensodyne, and Flonase. It also has a strong pipeline of potential new medicines and vaccines in various stages of development.
6. Corporate Responsibility: GSK is committed to conducting business responsibly and ethically, with a focus on sustainability, environmental stewardship, and improving access to healthcare for underserved populations.
7. Culture and Values: GSK prides itself on its diverse and inclusive workplace culture, guided by a set of core values that prioritize integrity, respect for people, and transparency.
Overall, GSK's size, history, focus on innovation and global health, diverse portfolio, commitment to corporate responsibility, and strong culture make it a unique and esteemed company in the pharmaceutical industry.
Interesting facts about the GlaxoSmithKline company
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π‘ Learn smarter stock picks with "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfkqEg TGVhcm4gc2 1hcnRlciBz dG9jayBwaW NrcyB3aXRo IDxpPiJUaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzIj wvaT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9wPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx MnB4OyBmb2 50LXNpemU6 IDEzcHg7IG NvbG9yOiAj NDQ0Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIG5v dyBhbmQgZ2 V0IG91ciBm cmVlIGVCb2 9rIAogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGI+VGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2Nrczwv Yj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIC0t PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8IS0t CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 1hcmdpbi10 b3A6IDE2cH g7IGZvbnQt c2l6ZTogMT RweDsgY29s b3I6ICM0ND Q7IGZvbnQt ZmFtaWx5Oi AtYXBwbGUt c3lzdGVtLC BCbGlua01h Y1N5c3RlbU ZvbnQsIFNl Z29lIFVJLC BSb2JvdG8s IEhlbHZldG ljYSBOZXVl LCBzYW5zLX NlcmlmOyBs aW5lLWhlaW dodDogMS42 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBIYXZlIH lvdSBoZWFy ZCBhYm91dC BvdXIgc2hv cnQgPHN0cm 9uZyBzdHls ZT0nZm9udC 13ZWlnaHQ6 IDYwMDsnPk RhaWx5IFZp ZGVvIE5ld3 NsZXR0ZXI8 L3N0cm9uZz 4/CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdodHRwcz ovL3d3dy5p bnNpZ2h0Zn VsdmFsdWUu Y29tL25ld3 NsZXR0ZXIu cGhwJyB0YX JnZXQ9J19i bGFuaycgc3 R5bGU9J2Nv bG9yOiAjMD A3QkZGOyB0 ZXh0LWRlY2 9yYXRpb246 IG5vbmU7IG ZvbnQtd2Vp Z2h0OiA1MD A7IG1hcmdp bi1sZWZ0Oi A2cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBGaW5kIG 91dCBtb3Jl CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 L2E+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAgICAgIC AgICAgICAt LT4KICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC Ag
What is the GlaxoSmithKline company's primary line of business?
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfmoAg RG9u4oCZdC BtaXNzIDxp PiJUaGUgQ2 hlY2tsaXN0 IFZhbHVlIE ludmVzdG9y IOKAlCBBIF NtYXJ0ZXIg V2F5IHRvIF BpY2sgU3Rv Y2tzIjwvaT 4g4oCUIGZy ZWUhCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IA==
What is the market opportunity of the GlaxoSmithKline company?
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π₯ Free eBook for new users: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfkaUg RnJlZSBlQm 9vayBmb3Ig bmV3IHVzZX JzOiA8aT4i VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr cyI8L2k+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIA==
SWOT analysis of the GlaxoSmithKline company
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
βοΈ Sign up to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" for free
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIOKcje+4 jyBTaWduIH VwIHRvIGdl dCA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIA==
Porter's Five Forces analysis for the GlaxoSmithKline company
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk6Ug R2V0IG91ci BmcmVlIGVC b29rIG5vdz ogPGk+IlRo ZSBDaGVja2 xpc3QgVmFs dWUgSW52ZX N0b3Ig4oCU IEEgU21hcn RlciBXYXkg dG8gUGljay BTdG9ja3Mi PC9pPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L3A+CgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID EycHg7IGZv bnQtc2l6ZT ogMTNweDsg Y29sb3I6IC M0NDQ7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIFNp Z24gdXAgbm 93IGFuZCBn ZXQgb3VyIG ZyZWUgZUJv b2sgCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8Yj5UaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzPC 9iPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwhLS 0KICAgICAg ICAgICAgIC AgICAgICAg ICAgPGRpdi BzdHlsZT0n bWFyZ2luLX RvcDogMTZw eDsgZm9udC 1zaXplOiAx NHB4OyBjb2 xvcjogIzQ0 NDsgZm9udC 1mYW1pbHk6 IC1hcHBsZS 1zeXN0ZW0s IEJsaW5rTW FjU3lzdGVt Rm9udCwgU2 Vnb2UgVUks IFJvYm90by wgSGVsdmV0 aWNhIE5ldW UsIHNhbnMt c2VyaWY7IG xpbmUtaGVp Z2h0OiAxLj Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIEhhdmUg eW91IGhlYX JkIGFib3V0 IG91ciBzaG 9ydCA8c3Ry b25nIHN0eW xlPSdmb250 LXdlaWdodD ogNjAwOyc+ RGFpbHkgVm lkZW8gTmV3 c2xldHRlcj wvc3Ryb25n Pj8KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxhIGhyZW Y9J2h0dHBz Oi8vd3d3Lm luc2lnaHRm dWx2YWx1ZS 5jb20vbmV3 c2xldHRlci 5waHAnIHRh cmdldD0nX2 JsYW5rJyBz dHlsZT0nY2 9sb3I6ICMw MDdCRkY7IH RleHQtZGVj b3JhdGlvbj ogbm9uZTsg Zm9udC13ZW lnaHQ6IDUw MDsgbWFyZ2 luLWxlZnQ6 IDZweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIEZpbmQg b3V0IG1vcm UKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICA=
What is the GlaxoSmithKline company's business model?
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfjoEg RnJlZSBkb3 dubG9hZCEg PGk+IlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3MiPC 9pPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDEy cHg7IGZvbn Qtc2l6ZTog MTNweDsgY2 9sb3I6ICM0 NDQ7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIFNpZ2 4gdXAgbm93 IGFuZCBnZX Qgb3VyIGZy ZWUgZUJvb2 sgCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8Yj5UaGUg Q2hlY2tsaX N0IFZhbHVl IEludmVzdG 9yIOKAlCBB IFNtYXJ0ZX IgV2F5IHRv IFBpY2sgU3 RvY2tzPC9i PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgLS0+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTZweD sgZm9udC1z aXplOiAxNH B4OyBjb2xv cjogIzQ0ND sgZm9udC1m YW1pbHk6IC 1hcHBsZS1z eXN0ZW0sIE JsaW5rTWFj U3lzdGVtRm 9udCwgU2Vn b2UgVUksIF JvYm90bywg SGVsdmV0aW NhIE5ldWUs IHNhbnMtc2 VyaWY7IGxp bmUtaGVpZ2 h0OiAxLjY7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IEhhdmUgeW 91IGhlYXJk IGFib3V0IG 91ciBzaG9y dCA8c3Ryb2 5nIHN0eWxl PSdmb250LX dlaWdodDog NjAwOyc+RG FpbHkgVmlk ZW8gTmV3c2 xldHRlcjwv c3Ryb25nPj 8KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID xhIGhyZWY9 J2h0dHBzOi 8vd3d3Lmlu c2lnaHRmdW x2YWx1ZS5j b20vbmV3c2 xldHRlci5w aHAnIHRhcm dldD0nX2Js YW5rJyBzdH lsZT0nY29s b3I6ICMwMD dCRkY7IHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsgZm 9udC13ZWln aHQ6IDUwMD sgbWFyZ2lu LWxlZnQ6ID ZweDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IEZpbmQgb3 V0IG1vcmUK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv YT4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIC0t PgogICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A=
What is the GlaxoSmithKline company's unique selling proposition?
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π Unlock our free guide: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCflJMg VW5sb2NrIG 91ciBmcmVl IGd1aWRlOi A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IA==
How does the GlaxoSmithKline company differentiate itself in the market?
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
β
Download "The Checklist Value Investor β A Smarter Way to Pick Stocks" β totally free!
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIOKchSBE b3dubG9hZC A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+IOKAlC B0b3RhbGx5 IGZyZWUhCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIA==
What are the GlaxoSmithKline company's potential challenges in the industry?
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfjoEg RnJlZSBkb3 dubG9hZCEg PGk+IlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3MiPC 9pPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDEy cHg7IGZvbn Qtc2l6ZTog MTNweDsgY2 9sb3I6ICM0 NDQ7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIFNpZ2 4gdXAgbm93 IGFuZCBnZX Qgb3VyIGZy ZWUgZUJvb2 sgCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8Yj5UaGUg Q2hlY2tsaX N0IFZhbHVl IEludmVzdG 9yIOKAlCBB IFNtYXJ0ZX IgV2F5IHRv IFBpY2sgU3 RvY2tzPC9i PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgLS0+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTZweD sgZm9udC1z aXplOiAxNH B4OyBjb2xv cjogIzQ0ND sgZm9udC1m YW1pbHk6IC 1hcHBsZS1z eXN0ZW0sIE JsaW5rTWFj U3lzdGVtRm 9udCwgU2Vn b2UgVUksIF JvYm90bywg SGVsdmV0aW NhIE5ldWUs IHNhbnMtc2 VyaWY7IGxp bmUtaGVpZ2 h0OiAxLjY7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IEhhdmUgeW 91IGhlYXJk IGFib3V0IG 91ciBzaG9y dCA8c3Ryb2 5nIHN0eWxl PSdmb250LX dlaWdodDog NjAwOyc+RG FpbHkgVmlk ZW8gTmV3c2 xldHRlcjwv c3Ryb25nPj 8KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID xhIGhyZWY9 J2h0dHBzOi 8vd3d3Lmlu c2lnaHRmdW x2YWx1ZS5j b20vbmV3c2 xldHRlci5w aHAnIHRhcm dldD0nX2Js YW5rJyBzdH lsZT0nY29s b3I6ICMwMD dCRkY7IHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsgZm 9udC13ZWln aHQ6IDUwMD sgbWFyZ2lu LWxlZnQ6ID ZweDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IEZpbmQgb3 V0IG1vcmUK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv YT4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIC0t PgogICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A=
What challenges did the GlaxoSmithKline company face in the recent years?
ππ Want to read more about GlaxoSmithKline?
Sign up for free
or
log in
π₯ Free eBook for new users: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfkaUg RnJlZSBlQm 9vayBmb3Ig bmV3IHVzZX JzOiA8aT4i VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr cyI8L2k+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIA==